TORL BioTherapeutics
Culver City, CA
TORL BioTherapeutics is a clinical-stage biopharmaceutical business focused on creating innovative, antibody-based medicines to improve the lives of cancer patients. They are developing a comprehensive pipeline of innovative preclinical ADCs and mAb in oncologic diseases with high unmet medical needs.
torlbio.comCompany Details
Founded
- 2018
Employees
- Between 5 - 20 employees
Raised
- $316,000,000
Headquarters Location
- Culver City, CA
Public
- No
Acquired
- No
CEO
Mark Alles
Company Collections
These are collections TORL BioTherapeutics is a part of. Click on the collection name to view similar companies.